Valuation Pfizer, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2025-01-17 pm EST			5-day change	1st Jan Change
26.30 ^USD	-0.72%		-1.57%	-0.87%

Jan. 17	Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	MT
Jan. 17	USA: 15 new drugs on the negotiation list	CF

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	216,827	204,605	331,440	287,626	162,560	149,042	149,042	-
Change	-	-5.64%	61.99%	-13.22%	-43.48%	-8.32%	0%	-
Enterprise Value (EV) ¹	259,147	232,220	338,807	300,723	221,758	207,272	201,317	196,294
Change	-	-10.39%	45.9%	-11.24%	-26.26%	-6.53%	-2.87%	-2.5%
P/E ratio	13.7x	21.5x	15.3x	9.37x	77.8x	15x	11.3x	11.2x
PBR	3.43x	3.24x	4.3x	3x	1.83x	1.67x	1.64x	1.59x
PEG	-	-0.5x	0x	0.2x	-0.8x	0x	0.3x	13.96x
Capitalization / Revenue	4.19x	4.88x	4.08x	2.87x	2.78x	2.36x	2.37x	2.36x
EV / Revenue	5.01x	5.54x	4.17x	3x	3.79x	3.29x	3.19x	3.11x
EV / EBITDA	12.3x	13x	13.3x	7.1x	14.2x	8.35x	8x	7.49x
EV / EBIT	13.3x	17.8x	16.7x	8.07x	23.8x	10.1x	9.52x	8.95x
EV / FCF	24.9x	19.1x	11.3x	11.6x	46.3x	17.6x	11.5x	11.7x
FCF Yield	4.02%	5.23%	8.82%	8.66%	2.16%	5.69%	8.66%	8.52%
Dividend per Share ²	1.44	1.52	1.56	1.61	1.65	1.666	1.7	1.715
Rate of return	3.68%	4.13%	2.64%	3.14%	5.73%	6.34%	6.46%	6.52%
EPS ²	2.87	1.71	3.85	5.47	0.37	1.756	2.331	2.35
Distribution rate	50.2%	88.9%	40.5%	29.4%	446%	94.9%	72.9%	73%
Net sales ¹	51,750	41,908	81,288	100,330	58,496	63,054	63,016	63,216
EBITDA ¹	21,097	17,801	25,426	42,336	15,590	24,826	25,149	26,198
EBIT ¹	19,420	13,024	20,235	37,272	9,300	20,581	21,144	21,932
Net income ¹	16,273	9,616	21,979	31,372	2,119	10,115	13,572	13,300
Net Debt ¹	42,320	27,615	7,367	13,097	59,198	58,230	52,275	47,252
Reference price ²	39.18	36.81	59.05	51.24	28.79	26.30	26.30	26.30
Nbr of stocks (in thousands)	5,534,122	5,558,397	5,612,867	5,613,315	5,646,413	5,666,990	5,666,990	-
Announcement Date	1/28/20	2/2/21	2/8/22	1/31/23	1/30/24	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield	Capi. ($)
PFIZER, INC.	14.97x	3.29x	8.35x	+6.34%	149B
ELI LILLY AND COMPANY	57.77x	14.92x	41.72x	+0.72%	653B
JOHNSON & JOHNSON	21.23x	4.11x	12x	+3.24%	354B
NOVO NORDISK A/S	25.72x	9.14x	18.41x	+1.90%	353B
ABBVIE INC.	38.17x	6.45x	14.22x	+3.63%	303B
MERCK & CO., INC.	13.9x	4.23x	10.08x	+3.11%	248B
ROCHE HOLDING AG	15.8x	3.77x	9.81x	+3.71%	234B
ASTRAZENECA PLC	24.7x	4.3x	13.46x	+2.33%	207B
NOVARTIS AG	17.88x	4.15x	10.6x	+3.88%	195B
AMGEN INC.	29.79x	5.9x	10.38x	+3.32%	146B
Average	25.99x	6.03x	14.90x	+3.22%	284.21B
Weighted average by Cap.	31.04x	7.52x	19.25x	+2.71%